GW Pharma Shares Indicated Up 8% Premarket On Light Volume (~3K Shares); Traders Earlier Circulated NBC WTHR 13 Article 'New CBD oil drug is first in U.S. recognized as legal under federal law', Referring To GW Pharma's Epidiolex